Should Bone Turnover Markers Be Used Routinely to Monitor Oral Bisphosphonate Osteoporosis Therapy? No: Measurement Is Unnecessary and a Poor Use of Medical Resources

MeSH terms

• Biomarkers
• Bone Density
• Bone Density Conservation Agents* / therapeutic use
• Bone Remodeling
• Diphosphonates / therapeutic use
• Female
• Humans
• Osteoporosis* / diagnosis
• Osteoporosis* / drug therapy
• Osteoporosis, Postmenopausal* / diagnosis
• Osteoporosis, Postmenopausal* / drug therapy